From: Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: A prospective observational study
ERBB2+
Triple-negative
Luminal
DTC in bone marrow
no
5 (71%)
15 (79%)
61 (78%)
ns
yes
2 (29%)
5 (21%)
4 (22%)
Disease-free
4 (21%)
2 (3%)
p = 0.001
76 (97%)